CMPX

Up next

Next earnings call

Nov 26, 2026 Est · unconfirmed · in 20 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 5, 2026

Equibles Rating blended score · not investment advice

Overall

Sell

SellHoldBuy

Technical Neutral Momentum Weak Sentiment Bullish Fundamentals Weak Quant / Vol Very High

Market backdrop VIX 15 · calm Equity put/call 0.55

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg −46%

below

Price vs 50-day avg +14%

above

RSI (14) 57

neutral

MACD trend Positive

52-week position 14%

near low

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Weak

1-month return +21%

trailing

6-month return −60%

trailing

YTD return −57%

this year

Relative strength −69%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $2 › 200d $4 — 200d above 50d

Institutional flow Accumulating

4 of 203 funds reported for Jun 30 · net +50.8K sh shares · +2 new

Insider flow Accumulating

Net +$75.6K over 90 days · 0% sells

Short interest Rising

20.62% of float · ▲ +14.3% MoM · 8.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

203 holders — near 3-yr high, broad support

Squeeze score 88

high risk · 0–100

Fundamentals

Weak

Revenue growth −100%

Y/Y

Free cash flow $-49.2M

Balance sheet $30.6M

net cash

Quant / Vol

risk profile

Very High

Volatility 94%

annualized · 1-yr

Max drawdown −74%

past year

ATR 5.9%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral

2 · 3 · 2

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−46% Bearish

Price vs 50-day avg

+14% Bullish

RSI (14)

57 Neutral

MACD trend

Positive Bullish

52-week position

14% Bearish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $2 › 200d $4 — 200d above 50d

Institutional flow Accumulating

4 of 203 funds reported for Jun 30 · net +50.8K sh shares · +2 new

Insider flow Accumulating

Net +$75.6K over 90 days · 0% sells

Short interest Rising

20.62% of float · ▲ +14.3% MoM · 8.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

203 holders — near 3-yr high, broad support

Price context

position in its 52-week range

52-wk low $2 Now $2 · 14% 52-wk high $7

vs 200-day avg -46% vs 50-day avg +14%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
Cash, cash equivalents and marketable securities	$209M	as of December 31, 2025	—
Estimated cash and marketable securities	$209M	as of December 31, 2025	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
CMPX Compass Therapeutics, Inc. this stock	$416.00M	-56.6%	-100.0%	—	20.6%
ONC BeOne Medicines Ltd.	$431.70B	-1.7%	+22179.2%	878.5	0.1%
VRTX Vertex Pharmaceuticals Inc / Ma	$123.19B	+7.1%	+46.2%	28.8	1.9%
REGN Regeneron Pharmaceuticals, Inc.	$69.63B	-13.8%	+20.8%	16.2	3.3%
ARGX Argenx SE	$54.85B	+4.4%	—	—	2.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

204

% held: 97.6%
Reported: 4 of 203
Top holder: TANG CAPITAL MANAGEMENT L…

Held Float

View

Held by Funds

Fund positions

144

View

Short & Settlement

Short Interest Rising

Shares short

37.1M

Days to cover: 8.9d
Change: +4.6M sh

View

Short Volume

Short vol %

30%

As of: Jul 10, 2026

Short Total

View

Fails to Deliver

FTD shares

319

Value: $644
As of: Jun 9, 2026

View

Off-Exchange

Off-exchange %

60.2%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net buying

Net (90d)

+$75.6K

Buyers / Sellers: 2 / 0

Buyers Sellers

View

Financials

Net income (FY)

$-66.5M

View

Filings

SEC Filings

Latest

8-K

Filed: Jul 1, 2026
This year: 10

View

Proposed Sales

Value

$5.7M

Shares: 3.6M
Filed: Apr 9, 2025

View

Exempt Offerings

Offering

$195.3M

Filed: Jul 1, 2020

View

Earnings & Events

Earnings Calls

Last call

May 20, 2026

View

	5D	20D	120D	MTD	YTD
CMPX	+2.6%	+21.4%	-59.8%	+6.4%	-56.6%
SPY	+1.4%	+4.1%	+9.1%	+1.1%	+10.7%
vs SPY	+1.3%	+17.3%	-68.9%	+5.3%	-67.3%

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance